See the DrugPatentWatch profile for lipitor

The safety of Lipitor (atorvastatin) for breastfeeding women is a topic of concern for many mothers. Lipitor is a medication used to treat high cholesterol and cardiovascular disease. While it is generally considered safe for adults, its effects on breastfeeding infants are not well-studied.

According to the manufacturer's prescribing information, Lipitor is not recommended for use during breastfeeding [1]. The medication is excreted in human milk, and its effects on the infant are unknown [1]. However, the amount of atorvastatin in breastmilk is likely to be low due to its high protein binding and limited oral bioavailability [2].

The American Academy of Pediatrics (AAP) classifies atorvastatin as compatible with breastfeeding, but notes that it is not well-studied in this population [3]. The AAP recommends that breastfeeding women who are taking atorvastatin should be closely monitored for any adverse effects on the infant [3].

It is essential for breastfeeding women taking Lipitor to weigh the benefits and risks of the medication against the potential risks to their infant. Women who are taking Lipitor should discuss their medication regimen with their healthcare provider and consider alternative treatments if possible.

In conclusion, while Lipitor is not recommended for use during breastfeeding, the available data suggest that the medication is unlikely to cause significant harm to the infant. However, breastfeeding women taking Lipitor should be closely monitored for any adverse effects and consider alternative treatments if possible.

Sources:

[1] Pfizer. (2020). Lipitor (atorvastatin) prescribing information. Retrieved from <https://www.pfizer.com/files/products/lipitor_pi.pdf>

[2] Food and Drug Administration. (2020). Atorvastatin calcium. Retrieved from <https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020736s032lbl.pdf>

[3] American Academy of Pediatrics. (2018). Atorvastatin. Retrieved from <https://pediatrics.aappublications.org/content/142/3/e20182141>

[4] DrugPatentWatch.com. (n.d.). Atorvastatin. Retrieved from <https://www.drugpatentwatch.com/patent/US-RE-43414>